Search results for "Alzheimer's Disease"
Biomarkers for Alzheimer's disease may aid diagnosis, predict dementia, studies find
A Swedish study found that blood biomarkers for Alzheimer's disease had high diagnostic accuracy in primary and secondary care, while a U.S. study found that the biomarkers' association with dementia may begin in midlife.
https://immattersacp.org/weekly/archives/2024/07/30/2.htm
30 Jul 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/09/latest-updates-on-acps-priorities-initiatives.htm
1 Sep 2024
Adults with subjective cognitive decline were more likely to report 4 modifiable risk factors for Alzheimer's disease
Among survey respondents ages 45 years and older, the most common modifiable risk factor for Alzheimer's disease and related dementias was hypertension (49.9%), followed by not meeting guidelines for aerobic physical activity (49.7%), obesity (35.3%), and diabetes (18.6%).
https://immattersacp.org/weekly/archives/2022/05/31/2.htm
31 May 2022
Managing Alzheimer's disease when options are limited
Primary care physicians can expect to diagnose an increasing number of patients with Alzheimer's disease as the U.S. population ages. While clinicians have been more successful in diagnosing the disease early, effective treatments or prevention options are more scarce.
https://immattersacp.org/archives/2016/03/alzheimers.htm
1 Mar 2016
Antihypertensive drugs linked with lower dementia risk in older patients
Patients who filled a new prescription for antihypertensive therapy more than three-quarters of the time were 24% less likely to develop dementia than those who rarely filled theirs, according to a seven-year study carried out in Italy among patients ages 65 years and older.
https://immattersacp.org/weekly/archives/2024/04/02/5.htm
2 Apr 2024
Point-of-care HCV test, new Alzheimer's drug approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/09/point-of-care-hcv-test-new-alzheimers-drug-approved.htm
1 Sep 2024
Delirium may be associated with adverse outcomes in hospitalized patients with Alzheimer's disease
Patients with Alzheimer's disease who develop delirium during hospitalization are more likely to have adverse outcomes, according to a new study.
https://immattersacp.org/weekly/archives/2012/06/19/4.htm
19 Jun 2012
Diagnose, address cognitive impairment in heart failure patients, society says
A new scientific statement from the Heart Failure Society of America advises clinicians to be alert to clues such as difficulty with money or running out of medicine, among other recommendations.
https://immattersacp.org/weekly/archives/2024/03/19/4.htm
19 Mar 2024
Major shift in thinking about cognitive impairment
Because neurocognitive decline can have a variety of etiologies, a new definition by the DSM-5 defined mild cognitive impairment as a syndrome, and then drilled down to its etiology.
https://immattersacp.org/archives/2019/07/major-shift-in-thinking-about-cognitive-impairment.htm
1 Jul 2019
Benzodiazepine use associated with increased risk of Alzheimer's disease
Patients who had taken benzodiazepines for at least 3 months had a 50% increased risk of Alzheimer's disease, a recent study of older patients found.
https://immattersacp.org/weekly/archives/2014/09/16/2.htm
16 Sep 2014